ORIEN network will accelerate data exchange – and new cancer therapies

February 23, 2015 | by Nicole White

With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments.

precision medicine City of Hope has joined ORIEN, the world's largest cancer research collaboration devoted to precision medicine.

The Oncology Research Information Exchange Network, or ORIEN, is the world's largest precision collaboration for cancer research, one that will enable researchers and clinicians to share data to accelerate the development of precision medicine treatments. This will allow patients to be more quickly matched to potentially lifesaving clinical trials, even as it leads to larger and richer analyses of data for research purposes.

ORIEN is anchored by the Moffitt Cancer Center and the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richaed J. Solove Research Institute. City of Hope joins the network at the same time as University of Virginia Cancer Center, University of Colorado Cancer Center and University of New Mexico Cancer Center, expanding the oncology network from coast to coast.

“Rapidly evolving science and modern diagnostics are moving the field of cancer research and cures forward, but it’s not something one institution can accomplish on its own,” said Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope and director of City of Hope's comprehensive cancer center. “City of Hope is proud to partner with Moffitt, the OSUCCC-James and the new ORIEN members to share data, collaborate and to ultimately change the cancer treatment model.”

The network will contribute to extensive databases with cancer patient information, such as medical history, cancer tissue and DNA, that can be used for basic research and clinical trials.

The expansion of the network allows for more than 50,000 new patients each year to have the opportunity to donate their tissue and clinical data to the network, and potentially help them be matched with ongoing clinical trials with the best chance to help them.

For City of Hope patients, membership in the network means expanded access to clinical trial offerings – all from National Cancer Institute-designated cancer centers.

The network partners with industry to accelerate and improve clinical trial efficiency, with the aim of bringing safe and effective treatments more quickly to all patients.


Learn more about becoming a patient or getting a second opinion at City of Hope by visiting our website or by calling 800-826-HOPE (4673). You may also request a new patient appointment online. City of Hope staff will explain what's required for a consult at City of Hope and help you determine, before you come in, whether or not your insurance will pay for the appointment.

Back To Top

Search Blogs